Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 14/8/2018
SIETES contiene 92466 citas

 
 
 1 a 20 de 22 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Grant PJ, Conlon A, Chopra V, Flanders SA. Use of venous thromboembolism prophylaxis in hospitalized patients. JAMA Intern Med 2018;178:1122-4. [Ref.ID 102646]
2. Cita con resumen
Kamerow D. Is hypertension really a neglected disease?. BMJ 2010;340:572. [Ref.ID 88117]
3. Cita con resumen
Suárez C, Ruiz-Giménez N. Anticoagulación preventiva: ejemplo de análisis de riesgo/beneficio. Rev Clin Esp 2009;209:157-9. [Ref.ID 85883]
4. Cita con resumen
Anónimo. Pain is poorly treated in Europe. BMJ 2007;335:846. [Ref.ID 81392]
5.Tiene citas relacionadas Cita con resumen
O'Byrne PM, Parameswaran K. Pharmacological management of mild or moderate persistent asthma. Lancet 2006;368:794-803. [Ref.ID 77960]
6.
Menson EN, Walker AS, Sharland M, Wells C, Tudor-Williams G, Riordan FAI, Lyall EGH, Gibb DM, for the collaborative HIV paediatric study steering committee. Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study. BMJ 2006;332:1183-886. [Ref.ID 77169]
7.
Gattellari M, Zwar NA, Worthington JM, Middleton S. Barriers to using warfarin in non-valvular atrial fibrillation. BMJ 2006;332:303-4. [Ref.ID 76079]
8. Cita con resumen
Piette J D, Heisler M, Wagner TH. Cost-related medication underuse. Do patients with chronic illnesses tell their doctors?. Arch Intern Med 2004;164:1749-55. [Ref.ID 71475]
9. Cita con resumen
Anónimo. US NIH to "detail" doctors about hypertension. Scrip 2004;2931:16. [Ref.ID 69466]
10.
Roberts J M, Villar J, Arulkumaran S. Preventing and treating eclamptic seizures. BMJ 2002;325:609-10. [Ref.ID 63434]
11. Cita con resumen
Schwenk TL. Prescription drug costs for the poor and the elderly. Journal Watch 2002;22:7. [Ref.ID 60117]
12. Cita con resumen
Salmeron S, Liard R, Elkharrat D, Muir J-F, Neukirch F, Ellrodt A, for the Asthme-Urgences (ASUR) study group, for the Societé Francophone de Médecine d'Urgence (SFMU), and Sociéte de Pneumologie de Langue Française. Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study. Lancet 2001;358:629-35. [Ref.ID 58270]
13.
Charatan F. Doctor disciplined for "grossly undertreating" pain. BMJ 1999;319:728. [Ref.ID 46845]
14. Cita con resumen
Vallano A, Aguilera C, Arnau JM, Baños JE, Laporte JR. Management of postoperative pain in abdominal surgery in Spain. A multicentre drug utilization study. Br J Clin Pharmacol 1999;47:667-73. [Ref.ID 45204]
15. Cita con resumen
Wunsch H. Anti-inflammatory drugs may be underused in cystic fibrosis. Lancet 1999;353:1335. [Ref.ID 44255]
16.
Bradford WD, Chen J, Krumholz HM. Under-utilisation of ß-blockers after acute myocardial infarction: pharmacoeconomic implications. Pharmacoeconomics 1999;15:257-68. [Ref.ID 43168]
18.
Brooks A. ß blockers should be used more widely after myocardial infarction. BMJ 1998;317:558. [Ref.ID 40357]
19.
Vlasses PH, Adarmes CJ. Underutilization of accepted therapies: an overlooked component of pharmaceutical care. Ann Pharmacother 1997;31:1537-8. [Ref.ID 36779]
20.
Gray D, Keating NA, Murdock J, Skene AM, Hampton JR. Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction. Lancet 1993;341:654-7. [Ref.ID 19058]
Seleccionar todas
 
 1 a 20 de 22 siguiente >>